health benefits of glp-1 agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies The Benefits of GLP-1 Therapy:

In the ELIXA trial, Pfeffer et al 27 evaluated the effect of lixisenatide in patients with type 2 diabetes with myocardial infarction or unstable angina admission in the previous 180 days

Your primary care provider or a specialist can help you weigh the pros and cons of GLP-1s

Instead, discuss implementing a bone health protection plan alongside your treatment

Various studies have found that, among patients with type 2 diabetes, a history of myocardial infarction or stroke, or arteriosclerotic cardiovascular disease, liraglutide use was associated with a lower incidence of cardiovascular disease than in the control group [16]